Adults with obesity or overweight and 1 obesity-related complication, without diabetes, who initiated tirzepatide or semaglutide December 2023June 2024 and adhered to treatment, were followed for 6 months
Our teams have been getting to know each other for a while, said Andrew Dudum, chief executive officer of Hims
Interestingly, while the ISM Manufacturing survey was very strong, including a decent boost to its employment gauge, the ADP manufacturing employment index continues to show job losses
Still, it once again demonstrates the potential for help that repurposed drugs, many of which have never been considered for these diseases, hold
But if you ask the Americans who have ever used GLP-1s themselves, many feel positively about both the long-term impact of the drugs and the effect the drugs will have on obesity in the nation.